Literature DB >> 14680720

Differential effects of milnacipran, fluvoxamine and paroxetine for depression, especially in gender.

Shigeru Morishita1, Seizaburo Arita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14680720     DOI： 10.1016/j.eurpsy.2003.05.002

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN： 0924-9338            Impact factor:   5.361


× No keyword cloud information.
  5 in total

1.  Japanese experience with milnacipran, the first serotonin and norepinephrine reuptake inhibitor in Japan.

Authors:  Teruhiko Higuchi; Mike Briley
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

2.  Does early improvement in depressive symptoms predict subsequent remission in patients with depression who are treated with duloxetine?

Authors:  Akitsugu Sueki; Eriko Suzuki; Hitoshi Takahashi; Jun Ishigooka
Journal:  Neuropsychiatr Dis Treat       Date:  2016-05-23       Impact factor: 2.570

3.  Differential clinical effects of fluvoxamine by the effect of age in Japanese female major depressive patients.

Authors:  Hisashi Higuchi; Kazuhiro Sato; Shingo Naito; Keizo Yoshida; Hitoshi Takahashi; Mitsuhiro Kamata; Noboru Yamaguchi
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

4.  Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early response.

Authors:  Tetsu Tomita; Norio Yasui-Furukori; Yasui-Furukori Norio; Yasushi Sato; Taku Nakagami; Shoko Tsuchimine; Ayako Kaneda; Sunao Kaneko
Journal:  Neuropsychiatr Dis Treat       Date:  2014-04-08       Impact factor: 2.570

5.  Study of Sex Differences in Duloxetine Efficacy for Depression in Transgenic Mouse Models.

Authors:  Yong Xu; Lei Ma; Wei Jiang; Yuhong Li; Gang Wang; Rena Li
Journal:  Front Cell Neurosci       Date:  2017-10-31       Impact factor: 5.505
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.